
Elena E Perez MD
Partner, Allergy Associates of the Palm Beaches
Join to view full profile
840 US Highway 1Ste 243Juno Beach, FL 33408
Phone+1 561-626-2006
Fax+1 561-626-8622
Dr. Perez is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Children's Hospital of PhiladelphiaFellowship, Allergy and Immunology, 2001 - 2004
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1998 - 2001
University of Florida College of MedicineClass of 1998
Certifications & Licensure
FL State Medical License 2009 - 2027
PA State Medical License 1999 - 2008
American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Publications & Presentations
PubMed
- Safety and tolerability of a new intravenous immunoglobulin 10% in patients with primary immunodeficiency.Roberto Crea, Elena Perez, Chaim M Roifman
Immunotherapy. 2026-08-07 - Clinical Evaluation of Pharmacokinetics, Efficacy, and Safety of a 10% Immunoglobulin in Primary Immunodeficiency Disease (CARES10 Study).Chaim M Roifman, Donald McNeil, William Lumry, Richard L Wasserman, Henry Kanarek
Advances in Therapy. 2026-07-01 - 2 citations2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAA...Jordan S Orange, Javier Chinen, Caroline C Horner, Lisa J Kobrynski, Mark Ballow
Annals of Allergy, Asthma & Immunology. 2026-04-01
Press Mentions
Kedrion Biopharma Announces First Patient Enrolled in CARES10, a Phase 3, Multi-Center Study to Assess a 10 Percent Intravenous Immunoglobulin in Adults with Primary Immunodeficiency DiseaseAugust 12th, 2019
GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-Stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)December 19th, 2023
Grant Support
- Uncovering Co-Stimulatory T Cell Help Defects In Common Variable ImmunodeficiencyNational Institute Of Allergy And Infectious Diseases2009–2010
- Engineering Primary T Cells For Resistance To HIV-1National Institute Of Allergy And Infectious Diseases2008
- Engineering Primary T Cells For Resistance To HIV-1National Institute Of Allergy And Infectious Diseases2004–2008
- Minority Predoctoral Fellowship Program--NigmsNational Institute Of General Medical Sciences1994–1996
- Minority Predoctoral Fellowship Program - NigmsNational Institute Of General Medical Sciences1991–1993
Committees
- Chairperson (former), Primary Immune Deficiency Committee AAAAI
- Chairperson (former), Basic and Clinical Immunology Interest Section AAAAI
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









